Item 2.02. Results of Operations and Financial Condition.

On August 9, 2021, the Registrant issued a press release announcing its results for the three and six months ended June 30, 2021. A copy of the press release is attached as Exhibit 99.1 to this Current Report and is incorporated herein by reference.

The information in this Form 8-K, including the accompanying exhibit, is being furnished under Item 2.02 and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.

We do not have, and expressly disclaim, any obligation to release publicly any updates or any changes in our expectations or any change in events, conditions, or circumstances on which any forward-looking statement is based.

The press release included in this Current Report is available on our website located at www.biohitech.com, although we reserve the right to discontinue that availability at any time.

Item 9.01. Financial Statements and Exhibits.





Number   Description
  99.1     Press Release from BioHiTech Global, Dated August 9, 2021, entitled
         "BioHiTech Global Reports Second Quarter 2021 Financial Results with
         Record Revenue"
104      The cover page from this Current Report on Form 8-K, formatted in Inline
         XBRL.

© Edgar Online, source Glimpses